Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 6, 1999, Pages 1054-1061

  Hoshino, Makoto ^a   Sim, JaeJoon ^a   Shimizu, Kunihiko ^a   Nakayama, Hiroyuki ^a   Koya, Ai ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway inflammation; Bronchial hyperresponsiveness; Chemokines; Thromboxane A2

Indexed keywords

CHEMOKINE; EOTAXIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; SERATRODAST; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; BRONCHITIS; BRONCHUS HYPERREACTIVITY; BRONCHUS REACTIVITY; CELL INFILTRATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; MALE; MEDIATOR RELEASE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032807704     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70179-X     Document Type: Article

References (38)

1. 1. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy subjects using immunohistochemistry. Am Rev Respir Dis 1990;142:863-71.
2. 2. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-74.
3. 3. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-13.
4. 4. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1993;323:1033-9.
5. 5. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975;72:2994-8.
6. 6. Svensson J, Strandberg K, Tuvemo T, Hamberg M. Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins 1977;14:425-36.
7. 7. Fairfax AJ, Hanson JM, Morley J. The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism. Clin Exp Immunol 1983;42:393-8.
8. 8. Fujimura M, Sasaki F, Nakatsumi Y, Takahashi Y, Hifumi S, Taga K, et al. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 1986;41:955-9.
9. 9. Shimada T, Matsumolo M, Wakabayashi S, Tomiyama A, Okazaki M. Effects of egualen sodium eyedrops on guinea pig conjunctiva. Jpn J Ocular Pharm 1995;9:35-9.
10. 10. Takami M, Matsumoto K, Takata Y, Furuhama K, Tsukada W. Possible role of thromboxane A2 in hyperresponsiveness of isolated rat lung tissue in sephadex-induced eosinophilia model. Int Arch Allergy Immunol 1995;106:401-9.
11. 11. Nusing, R, Ullrich V. Immunoquantitation of thromboxane synthase in human tissues. Eicosanoids 1990;3:175-80.
12. 12. Namba T, Sugimoto Y, Hirata M, Hayashi Y, Honda A, Watanabe A, et al. Mouse thromboxane A2 receptor: cDNA cloning, expression and northern blot analysis. Biochem Biophys Res Commun 1992;184:1197-203.
13. 13. Itoh K, Mukaiyama O, Satoh Y, Yamaguchi T, Iizuka Y. Effects of CS-5181, a thromboxane synthase inhibitor, on eosinophil function. Eur J Pharmacol 1993;239:159-69.
14. 14. Agrawal DK, Takami M, Ono S-E. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation. Inflammation 1997;21:1-8.
15. 15. Shi H, Yokoyama A, Kohno N, Hirasawa Y, Kondo K, Sakai K, et al. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice. Eur Respir J 1998;11:624-9.
16. 16. Shiraishi M, Kato K, Terao S, Ashida Y, Terashita Z, Kito G. Quinines. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluation. J Med Chem 1989;32:2214-21.
17. 17. Ashida Y, Matsumoto T, Kuriki H, Shiraishi M, Kato K, Terao S. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. Prostaglandins 1989;38:91-112.
18. 18. Hiramoto A, Makino N, Achida Y. The effect of AA-2414 (seratrodust) on the production of cytokines in antigen-sensitized splenic mononuclear cells [abstract]. Jpn J Allergol 1997;46:825.
19. 19. Fujimura M, Sakamoto S, Saito M, Miyake Y, Matsuda T. Effects of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 1991;87:23-7.
20. 20. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994;15:127-33.
21. 21. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1988;136:225-44.
22. 22. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981;80:600-6.
23. 23. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP Complexes). J Histochem Cytochem 1984;32:219-29.
24. 24. Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R, et al. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol 1997;16:1-8.
25. 25. Kuhn DC, Stauffer JL, Gaydos W, Lacey SL, Demers LM. An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophages. Prostaglandins 1993;46:195-205.
26. 26. Caughey GE, Pouliot M, Cleland LG, James MJ. Regulation of tumor necrosis factor-α and IL-1β synthesis by thromboxane A2 in nonadherent human monocytes. J Immunol 1997;158:351-8.
27. 27. Narita S, Asakura K, Kataura A. Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 1996;109:161-6.
28. 28. Foegh ML, Maddox YT, Ramwell PW. Human peritoneal eosinophils and formation of arachidonate cyclooxygenase products. Scand J Immunol 1986;23:599-603.
29. 29. Stellato C, Beck LA, Gorgone GA, Proud D, Schall TJ, Ono SJ, et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line. J Immunol 1995;155:410-8.
30. 30. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996;14:27-35.
31. 31. Berkman N, Krishnan VL, Gilbey T, Newton R, O'Connor B, Barnes PJ, et al. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med 1996;154:1804-11.
32. 32. Devergne O, Marfaing-Koda A, Schall TT, Leger-Ravet M-B, Sadick M, Peuchmaur M, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689-94.
33. 33. Lukacs NW, Strieter RM, Shaklee CH, Chensue SW, Kunkel SL. Macrophage inflammatory protein-1α influences eosinophil recruitment in antigen-specific airway inflammation. Eur J Immunol 1995;25:245-51.
34. 34. Ying S, Meng Q, Taborda-Barata L, Corrigan CJ, Barkans J, Assoufi B, et al. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol 1996;26:70-6.
35. 35. Ying S, Taborda-Barata L, Meng Q, Humbert M, Kay AB. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotaclic protein-3 and RANTES in the skin of human atopic subjects: Relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 1995;181:2153-9.
36. 36. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988;141:1018-25.
37. 37. Davatelis G, Tekamp-Olson P, Wolpe SD, Hermsen K, Luedke C, Gallegos C, et al. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J Exp Med 1988;167:1939-44.
38. 38. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982;37:423-9.